posted
Posted by: transam73wi In reply to: None Date:9/8/2006 12:53:14 PM Post #of 45330
I have comfirmed (for myself) that Xechem will indeed be presenting at the 34th Annual SCDAA conference on Friday Sept. 29th from 4:00 p.m. to 5:00 p.m. as part of the "Simultaneous Sessions". Also, they will be participating in the "Plenary Panel" hosted by the Children's Hospital of Philadelphia at 8:30 a.m.
It will be Dr. Pandey that will be speaking.
1-800-421-8453; Sterling
WE MUST GET XKEM TO PR THIS.............. anyone?
I asked if you had to be a member of one of the member organizations to attend, and he said no, I would have to pay the full registration price even just to attend these two sessions. But an average Joe like me is welcome and encouraged to attend.
Also, they must have known about this all along, becuase the deadline to present was June 16th, 2006 Hmmmmmmmmm
SICKLE CELL DISEASE ASSOCIATION OF AMERICA, INC. 34th Annual Convention CALL FOR ABSTRACTS
Authors interested in presenting data should submit an abstract using the form in this program. All approved abstracts will be published in the final program to be distributed to attendees of the conference.
Acceptance notification and further instructions will be e-mailed on July 28, 2006. All correspondence will be sent to the name and e-mail address on the abstract form.
posted
Posted by: keepthfaith In reply to: transam73wi who wrote msg# 45326 Date:9/8/2006 12:59:18 PM Post #of 45330
It has also NOW been confirmed by Steve Burg. He also told me that he's trying to contact Dr Pandey, in order to put out a pr about his upcoming presentation. Steve's exact words were that "there has been an outcry from shareholders" for more info. Good job to those among us who have called him in the past day or two. Keep up the calls and phone messages, as the pr isnt a done deal until it's out.
The Big Money managers on Wall St are returning from their summer Vacation THIS WEEK!
They are looking for OTCBB stocks with huge potential and XKEM is one of them. XKEM has experienced tremendous Money Flow this 3rd Quarter [w/ $31,000,000.00 trading in one day recently, THAT'S HUGE FOR A PENNY STOCK!!!]
The Hedge Fund Managers are going to exploit, manipulate and INFLATE XKEM's pps, volume and Money Flow returning >5,000% profit for new buyers under 3cents.
The brief 200% spike-up in June for XKEM is only a fraction of what is ABOUT TO TAKE PLACE!!!
The 'Shorts' have squeezed Main St Longs who paid 6, 7, 8,9,10 and 11cents and many of those Main St sheep are selling and/or sold recently taking a 70% hair-cut on their investment.
XKEM is poised to have the similar rally that PTSC had in Q-1 '06 rising from 7cents to near $2.00 in 3 months time.
Folks this XKEM product; NICOSAN/HEMOXIN, which has received United States Food and Drug Administration (FDA)-designated orphan drug status as the first definitive therapy for sickle cell disease (SCD) and it has what it takes to get the Hedge Fund Managers ATTENTION!!!
Buy and Hold until Christmas and you'll all thank me. btw, MERRY CHRISTMAS!!!
Ps another trading fact that few Main St investors are privy to is that OTCBB 4th Quarter volume is on average the highest in order for the Hedge Funds to show their Millionaire clients HUGE % GAINS for the end of the year tax returns.
YOU can now join the once exclusive Wall St Millionaire Club or watch the rich get richer, YOU DECIDE!!!
IP: Logged |
posted
I'd be happy if there was even 10% truth to that...we'll just have to wait and see....it would definitely be a nice Christmas present for all of us..lol
IP: Logged |
Xechem Chairman, Dr. Ramesh Pandey, to Present NICOSAN(TM) Story at 34th Annual SCDAA Conference in Dallas Business Wire - September 12, 2006 07:30
NEW BRUNSWICK, N.J., Sep 12, 2006 (BUSINESS WIRE) -- Xechem International, Inc. (OTC BB: XKEM) announced today that its Chairman and CEO, Dr. Ramesh C. Pandey, has accepted an invitation to make a presentation on NICOSAN(TM), the Company's promising new sickle cell drug, at the Sickle Cell Disease Association of America's (SCDAA) 34th Annual Conference. The Conference will be held at the Hyatt Regency Hotel in Dallas, Texas, September 27th through September 30th, 2006. More than 500 physicians, researchers, scientists, nurses and others in the medical community from throughout the country and around the world are expected to attend the Conference, which is also expected to draw a number of sickle cell patients and their family members.
Dr. Pandey will speak as part of a Special Panel entitled "Treatment Options and Clinical Trials" on "The Nigerian Experience in the Development of a New Anti-Sickling Natural Herbal Drug." The Company will also set up a poster presentation during the Conference that will afford Xechem the opportunity to present to delegates the credible scientific and medical data that demonstrate both the efficacy and non-toxicity of NICOSAN(TM) (named HEMOXIN(TM) in the US).
According to Dr. Pandey, "It is a fortunate coincidence that this prestigious conference is being held so soon after NICOSAN(TM) was approved by Nigerian drug regulators, National Agency for Food and Drug Administration and Control (NAFDAC) and launched in Nigeria for sale on July 6th, 2006, by His Excellency, Chief Olusegun Obasanjo, GCFR, the President and Commander-in-Chief of the Armed Forces of the Federal Republic of Nigeria. I look forward to presenting to the Conference delegates a summary of the very positive developments regarding what we feel is a truly historic drug. Given the few treatment options currently available for sickle cell sufferers, and the proven efficacy and safety of this drug, I have no doubt that the presentation will be favorably received by those in attendance."
About Sickle Cell Disease
Sickle Cell Disease (SCD) is an inherited blood disorder caused by an abnormality in the hemoglobin molecule. Patients with the disease often produce stiff, abnormally shaped red blood cells that often do not flow freely through the blood vessels. This can create clogs in the vessels, which in turn can cut off the flow of normal hemoglobin and oxygen to parts of the body, and can cause severe painful attacks or "crises", damage to various organs and shortened life spans. People with SCD often suffer unpredictable painful crises several times a year lasting from a few hours to a week or more. In the US, there are approximately 80,000 patients with SCD. In Nigeria, that number is believed to be approximately 4 million, with an estimated 10 - 12 million sufferers throughout the African continent. Worldwide, at least 16 million individuals are believed to be afflicted with SCD.
About Xechem
Xechem International is a development stage biopharmaceutical company working on Sickle Cell Disease (SCD), antimalarials, and antiviral (including AIDS), anticancer, antifungal and antibacterial products from natural sources, including microbial and marine organisms. Its focus is on the development of phyto-pharmaceuticals (Natural Herbal Drugs) and other proprietary technologies, including those used in the treatment of orphan diseases. Xechem's mission is to bring relief to the millions of people who suffer from these diseases. Its recent focus and resources have been directed primarily toward the development and launch of NICOSAN(TM) (named HEMOXIN(TM) in the US and Europe) for the prophylactic management of Sickle Cell Disease (SCD). With the recent Nigerian regulatory approval of NICOSAN(TM), Xechem is now scaling-up the commercialization of the drug in Nigeria and making preparations for the pursuit of US FDA and European regulatory approval. In addition to NICOSAN(TM), Xechem is also working on another sickle cell compound, 5-HMF, which it has licensed from Virginia Commonwealth University (VCU).
Forward Looking Statements
This press release contains certain forward looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and section 21E of the Securities and Exchange Act of 1934, as amended, which are intended to be covered by safe harbors created hereby. Such forward looking statements involve known and unknown risks and uncertainties.
SOURCE: Xechem International, Inc.
Xechem International, Inc. Stephen Burg, 707-425-8855
Copyright Business Wire 2006
-------------------- "Great Day for Up!"....Dr. Seuss
IP: Logged |
The Big Money managers on Wall St are returning from their summer Vacation THIS WEEK!
They are looking for OTCBB stocks with huge potential and XKEM is one of them. XKEM has experienced tremendous Money Flow this 3rd Quarter [w/ $31,000,000.00 trading in one day recently, THAT'S HUGE FOR A PENNY STOCK!!!]
The Hedge Fund Managers are going to exploit, manipulate and INFLATE XKEM's pps, volume and Money Flow returning >5,000% profit for new buyers under 3cents.
The brief 200% spike-up in June for XKEM is only a fraction of what is ABOUT TO TAKE PLACE!!!
The 'Shorts' have squeezed Main St Longs who paid 6, 7, 8,9,10 and 11cents and many of those Main St sheep are selling and/or sold recently taking a 70% hair-cut on their investment.
XKEM is poised to have the similar rally that PTSC had in Q-1 '06 rising from 7cents to near $2.00 in 3 months time.
Folks this XKEM product; NICOSAN/HEMOXIN, which has received United States Food and Drug Administration (FDA)-designated orphan drug status as the first definitive therapy for sickle cell disease (SCD) and it has what it takes to get the Hedge Fund Managers ATTENTION!!!
Buy and Hold until Christmas and you'll all thank me. btw, MERRY CHRISTMAS!!!
Ps another trading fact that few Main St investors are privy to is that OTCBB 4th Quarter volume is on average the highest in order for the Hedge Funds to show their Millionaire clients HUGE % GAINS for the end of the year tax returns.
YOU can now join the once exclusive Wall St Millionaire Club or watch the rich get richer, YOU DECIDE!!!
posted
nothing yet Greenday...but Pandey is back from his trip to Nigeria now..the last loan they got from Nexim Bank of Nigeria wasn't PR'd until about 10 days after it was signed and Pandey had returned to the US...So more than likely if the loan didn't fall through, it should have been signed while he was in Nigeria...hopefully we get it soon..
IP: Logged |
posted
I wonder if this has anything to do witht he anticipation of the conference? seems a little early for a run due to that. I think some of pumpers on Ihub are looking at this one also right now. Looks nice right now!
-------------------- learnin as I go.
IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
![[Cool]](cool.gif)
